4-oxo-2-nonenal has been researched along with Neuroblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krewenka, C; Moldzio, R; Pohl, EE; Vazdar, K; Zimmermann, L | 1 |
| Lee, HG; Lee, HP; Perry, G; Sayre, LM; Skidmore, SC; Smith, MA; Zhu, X | 1 |
| Iio, K; Kawaguchi, M; Kawai, Y; Kobayashi, M; Shibata, N; Shibata, T; Toi, S; Uchida, K; Yamamoto, K | 1 |
3 other study(ies) available for 4-oxo-2-nonenal and Neuroblastoma
| Article | Year |
|---|---|
Nutrient deprivation in neuroblastoma cells alters 4-hydroxynonenal-induced stress response.
Topics: Aldehydes; Animals; Cell Line, Tumor; Cell Shape; Cell Survival; Energy Metabolism; Glucose; Glutamine; Lipid Peroxidation; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neuroblastoma; Oxidation-Reduction; Oxidative Stress; Time Factors | 2017 |
The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells.
Topics: Aldehydes; Cell Death; Cell Line, Tumor; Collagen Type XI; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Humans; L-Lactate Dehydrogenase; MAP Kinase Kinase 4; Neuroblastoma; Time Factors; Tumor Suppressor Protein p53 | 2009 |
Identification of a lipid peroxidation product as a potential trigger of the p53 pathway.
Topics: Aldehydes; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA Fragmentation; DNA-Binding Proteins; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Humans; Immunohistochemistry; Lipid Peroxidation; Models, Chemical; Neuroblastoma; Neurons; Oxygen; Phosphorylation; Proteasome Endopeptidase Complex; Protein Binding; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Time Factors; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Ubiquitin | 2006 |